share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 4 02:01
Summary by Futu AI
Charles F. Wagner Jr., an officer at Vertex Pharmaceuticals Inc., is set to sell 3,250 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,495,000. The shares to be sold were acquired through restricted stock vesting as part of compensation on various dates in February 2023, with a total of 3,250 shares vested. Wagner's transaction follows a consistent pattern of selling vested shares, as reflected in the past three months' sales data, where the same number of shares were sold for gross proceeds of $1,478,067.50. The planned sale is in accordance with a pre-arranged trading plan adopted on 02/26/2024.
Charles F. Wagner Jr., an officer at Vertex Pharmaceuticals Inc., is set to sell 3,250 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,495,000. The shares to be sold were acquired through restricted stock vesting as part of compensation on various dates in February 2023, with a total of 3,250 shares vested. Wagner's transaction follows a consistent pattern of selling vested shares, as reflected in the past three months' sales data, where the same number of shares were sold for gross proceeds of $1,478,067.50. The planned sale is in accordance with a pre-arranged trading plan adopted on 02/26/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.